SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽Demo🎬Demo VideoℹVision

Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

Mitochondrial Dysfunction-Mediated Neurodegeneration in Alzheimer's Disease

TFAM · - · -
Composite
0.380
Price
$0.00
Evidence For
0
Evidence Against
0

This hypothesis proposes that mitochondrial dysfunction represents a primary pathogenic mechanism in Alzheimer's disease, operating through impaired ATP synthesis and increased oxidative stress that precedes and drives amyloid-beta accumulation. Specifically, mutations or age-related damage to TFAM (Transcription Factor A, Mitochondrial) lead to defective mitochondrial DNA replication and reduced expression of respiratory chain complexes I and IV. This mitochondrial impairment creates a bioenerg

APOE-Dependent Autophagy Restoration

MTOR · neurodegeneration · therapeutic
Composite
0.895
Price
$0.65
Evidence For
0
Evidence Against
0

## Mechanistic Overview APOE-Dependent Autophagy Restoration proposes targeting the mechanistic link between apolipoprotein E4 (APOE4) genotype and impaired macroautophagy as a precision therapeutic strategy for Alzheimer's disease. APOE4, carried by ~25% of the population and present in ~65% of AD patients, disrupts autophagosome biogenesis, lysosomal acidification, and autophagic flux through multiple converging mechanisms. Restoring autophagy specifically in APOE4 carriers represents an isof

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

Autophagy LysosomeMitochondrial Dysfunction
Convergent signals
  • No same-target convergence detected in this selection.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

0/11
dimensions won
Mitochondrial Dysfunction-Mediated Neuro
11/11
dimensions won
APOE-Dependent Autophagy Restoration

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.75
0.85
Evidence
0.22
0.75
Novelty
0.00
0.60
Feasibility
0.00
0.90
Impact
0.00
0.80
Druggability
0.00
0.95
Safety
0.00
0.70
Competition
0.00
0.80
Data
0.00
0.85
Reproducible
0.00
0.80
KG Connect
0.27
0.96

Score Breakdown

DimensionMitochondrial Dysfunction-MediAPOE-Dependent Autophagy Resto
Mechanistic0.7500.850
Evidence0.2200.750
Novelty0.0000.600
Feasibility0.0000.900
Impact0.0000.800
Druggability0.0000.950
Safety0.0000.700
Competition0.0000.800
Data0.0000.850
Reproducible0.0000.800
KG Connect0.2730.965

Evidence

Mitochondrial Dysfunction-Mediated Neurodegeneration in Alzh

No evidence citations yet

APOE-Dependent Autophagy Restoration

No evidence citations yet

Price History Overlay

Knowledge Graph Comparison

Mitochondrial Dysfunction-Mediated Neuro

29 edges
Top Node Types
protein8
gene8
mechanism4
biomarker3
pathway2
Top Relations
causes16
causal_extracted2
associated_with2
indicates2
modulates2

APOE-Dependent Autophagy Restoration

29 edges
Top Node Types
protein8
gene8
mechanism4
biomarker3
pathway2
Top Relations
causes16
causal_extracted2
associated_with2
indicates2
modulates2

Pathway Diagrams

Curated mechanism pathway diagrams from expert analysis

Mitochondrial Dysfunction-Mediated Neurodegenerati

graph TD
A[APOE4] --> B[ABCA1]

APOE-Dependent Autophagy Restoration

graph TD
    A["""APOE4 Expression"""] -->|"Enhanced Domain Interaction"| B["Altered Receptor Signaling
LRP1/LDLR/HSPG"]
    B -->|"Reduced Akt Activation"| C["GSK3beta Activation"]
    B -->|"Enhanced Ras/MAPK"| D["mTORC1 Hyperactivation"]
    C -->|"Phosphorylates"| E["ULK1 Inactivation"]
    D -->|"Phosphorylates"| E
    D -->|"Phosphorylates"| F["TFEB Cytoplasmic
Sequestration"]
    E -->|"Reduced"| G["Autophagosome Initiation
PI3K/VPS34 Recruitment"]
    F -->|"Suppressed"| H["CLEAR Gene Transcription
LAMP1/LAMP2/CathD"]

    G -->|"Impaired"| I["Autophagosome
Formation"]
    H -->|"Reduced"| J["Lysosomal Biogenesis
& Degradative Capacity"]

    I --> K["Autophagy Flux
Impairment"]
    J --> K

    K -->|"Accumulation"| L["Protein Aggregates
Abeta/Tau/p62"]
    K -->|"Accumulation"| M["Damaged Mitochondria
ROS Generation"]

    L --> N["Neuronal Dysfunction
& Neurodegeneration"]
    M --> N

    O["""Therapeutic Intervention
mTOR Inhibition / TFEB Activation"""] -->|"Restores"| P["ULK1 Activation
+ TFEB Nuclear Translocation"]
    P -->|"Enhances"| Q["Autophagy Flux
Restoration"]
    Q -->|"Clears"| R["Abeta/Tau Aggregates
Damaged Organelles"]
    R -->|"Prevents"| S["Neuroprotection in
APOE4 Carriers"]

    style A fill:#ff8a80,stroke:#d32f2f,color:#000
    style O fill:#4fc3f7,stroke:#2196f3,color:#000
    style S fill:#81c784,stroke:#4caf50,color:#000
    style N fill:#ffab91,stroke:#e64a19,color:#000
← Back to Exchange